PMID: 7371703Feb 1, 1980Paper

Serum level of ritodrine in man

European Journal of Clinical Pharmacology
R GandarJ B van der Schoot

Abstract

A sensitive radioimmunoassay has been developed for the determination of ritodrine in serum and plasma. Interference by ritodrine metabolites, viz. the sulphate and glucuronide conjugates, was negligible. The sensitivity was 0.3 ng/ml in 0.1 ml plasma or serum. The method was used to determine the serum level of ritodrine in man after oral or parenteral administration. In healthy volunteers intravenous infusion of 9 mg in 1 h resulted in a peak serum level of about 45 ng/ml. In every subject the heart rate varied with time in approximately the same way as the serum level. Intramuscular injection of 10 mg gave a peak level of 20 ng/ml, and after oral administration of 10 mg the maximum peak concentration was 10 ng/ml. In all instances there was a detectable level in serum for up to 25 h after dosing. The bioavailability of the oral formulation was 30% of the parenteral preparations. The effective half-life was 1.3--2 h. Women in pre-term labour were treated by intravenous infusion of ritodrine hydrochloride, and after parturition, ritodrine was determined in serum from the mother and from umbilical cord blood. The results showed that ritodrine crossed the placental barrier and entered the fetal circulation.

References

Jul 1, 1976·Journal of Pharmaceutical Sciences·A J Sedman, J G Wagner
Jan 1, 1976·Antonie van Leeuwenhoek·W J MiddelhovenH P Egmond
Feb 1, 1973·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M E EvansJ W Paterson
Jul 1, 1969·The Journal of Obstetrics and Gynaecology of the British Commonwealth·O GamissansV Maiques

❮ Previous
Next ❯

Citations

Jan 1, 1985·European Journal of Clinical Pharmacology·A S Gross, K F Brown
Mar 1, 1983·European Journal of Obstetrics, Gynecology, and Reproductive Biology·J M TzafettasA C Papaloucas
Nov 1, 1986·European Journal of Obstetrics, Gynecology, and Reproductive Biology·S FujimotoA Sakai
Nov 1, 1986·European Journal of Obstetrics, Gynecology, and Reproductive Biology·U Ekblad
May 1, 1990·European Journal of Obstetrics, Gynecology, and Reproductive Biology·M GemelliF Martino
Jan 4, 1991·European Journal of Obstetrics, Gynecology, and Reproductive Biology·S FujimotoM Akahane
May 1, 1992·British Journal of Obstetrics and Gynaecology·J DeutingerG Bernaschek
Dec 1, 1993·British Journal of Obstetrics and Gynaecology·C A HolleboomM J Keirse
Jul 1, 1996·British Journal of Obstetrics and Gynaecology·C A HolleboomM J Keirse
Jan 1, 1982·Journal of Perinatal Medicine·M van Lierde, K Thomas
Jul 12, 2012·Drug Development and Industrial Pharmacy·Osamu Sakata, Hiraku Onishi
Sep 1, 1988·American Journal of Obstetrics and Gynecology·F R WitterJ Anderson
Aug 15, 1985·American Journal of Obstetrics and Gynecology·M BorrisudB D Andresen
Feb 1, 1990·American Journal of Obstetrics and Gynecology·S N CaritisM Krew
Jun 2, 2015·Biological & Pharmaceutical Bulletin·Hiraku OnishiKei Yumoto
Oct 1, 1987·European Journal of Obstetrics, Gynecology, and Reproductive Biology·C A HolleboomL W van Elferen
Aug 1, 1984·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·S FujimotoA Sakai
Oct 1, 1985·The Journal of Pediatrics·D Tenenbaum, R M Cowett
Nov 1, 1983·The Journal of Pediatrics·N B HansenB S Stonestreet
Apr 9, 2014·International Journal of Pharmaceutics·Hiraku OnishiOsamu Sakata
Sep 18, 2004·British Journal of Clinical Pharmacology·Nurullah OkumusTuncay Nas
Jul 1, 1986·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·R F Lamont, M G Elder

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.